Clinical trial
Prospective, Investigator Initiated Feasibility Study to Evaluate the Safety, and Indicative Effectiveness of Gebauer™ Lenticules in Patients Suffering From Severe Keratoconus or Post LASIK Ectasia
NCT04741230 is registered in ClinicalTrials.gov with The Royal Wolverhampton Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Investigator Initiated Feasibility Study to Evaluate the Safety, and Indicative Effectiveness of Gebauer™ Lenticules in Patients Suffering From Severe Keratoconus or Post LASIK Ectasia
- Lead sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 15, 2024
- Completion date
- December 1, 2026
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
keratoconus, post-laser retinal condition